These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17492757)

  • 1. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma.
    Parikh RA; White JS; Huang X; Schoppy DW; Baysal BE; Baskaran R; Bakkenist CJ; Saunders WS; Hsu LC; Romkes M; Gollin SM
    Genes Chromosomes Cancer; 2007 Aug; 46(8):761-75. PubMed ID: 17492757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
    Sankunny M; Parikh RA; Lewis DW; Gooding WE; Saunders WS; Gollin SM
    Genes Chromosomes Cancer; 2014 Feb; 53(2):129-43. PubMed ID: 24327542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q.
    Jin Y; Höglund M; Jin C; Martins C; Wennerberg J; Akervall J; Mandahl N; Mitelman F; Mertens F
    Genes Chromosomes Cancer; 1998 Aug; 22(4):312-20. PubMed ID: 9669669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between FRA11F and 11q13 gene amplification in oral cancer.
    Reshmi SC; Huang X; Schoppy DW; Black RC; Saunders WS; Smith DI; Gollin SM
    Genes Chromosomes Cancer; 2007 Feb; 46(2):143-54. PubMed ID: 17099871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
    Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 amplification in chromosomal band 11q13 is associated with overrepresentation of 3q21-q29 in head and neck carcinomas.
    Jin Y; Jin C; Wennerberg J; Höglund M; Mertens F
    Int J Cancer; 2002 Mar; 98(3):475-9. PubMed ID: 11920603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma.
    González MB; Hernández JM; García JL; Lumbreras E; Castellanos M; Hernández JM; Fernández-Calvo J; Gutiérrez NC; San Miguel JF
    Haematologica; 2004 Oct; 89(10):1213-8. PubMed ID: 15477206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
    Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
    Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer.
    Alavi S; Namazie A; Calcaterra TC; Wang MB; Srivatsan ES
    Laryngoscope; 1999 Jun; 109(6):874-9. PubMed ID: 10369274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma.
    Mansour WY; Bogdanova NV; Kasten-Pisula U; Rieckmann T; Köcher S; Borgmann K; Baumann M; Krause M; Petersen C; Hu H; Gatti RA; Dikomey E; Dörk T; Dahm-Daphi J
    Radiother Oncol; 2013 Jan; 106(1):147-54. PubMed ID: 23199656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
    Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
    J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breaks invisible to the DNA damage response machinery accumulate in ATM-deficient cells.
    Martín M; Terradas M; Iliakis G; Tusell L; Genescà A
    Genes Chromosomes Cancer; 2009 Sep; 48(9):745-59. PubMed ID: 19455703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification.
    Reshmi SC; Roychoudhury S; Yu Z; Feingold E; Potter D; Saunders WS; Gollin SM
    Cytogenet Genome Res; 2007; 116(1-2):46-52. PubMed ID: 17268177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.
    Wang MB; Alavi S; Engstrom M; Lee J; Namazie A; Moatamed F; Srivatsan ES
    Anticancer Res; 1999; 19(2A):925-31. PubMed ID: 10368635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
    Austen B; Skowronska A; Baker C; Powell JE; Gardiner A; Oscier D; Majid A; Dyer M; Siebert R; Taylor AM; Moss PA; Stankovic T
    J Clin Oncol; 2007 Dec; 25(34):5448-57. PubMed ID: 17968022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
    Taylor AM; Groom A; Byrd PJ
    DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13.
    Venugopalan M; Wood TF; Wilczynski SP; Sen S; Peters J; Ma GC; Evans GA; Srivatsan ES
    Cancer Genet Cytogenet; 1998 Jul; 104(2):124-32. PubMed ID: 9666806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.